Your browser doesn't support javascript.
loading
Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix.
Mendaza, Saioa; Fernández-Irigoyen, Joaquín; Santamaría, Enrique; Arozarena, Imanol; Guerrero-Setas, David; Zudaire, Tamara; Guarch, Rosa; Vidal, August; Salas, José-Santos; Matias-Guiu, Xavier; Ausín, Karina; Gil, Carmen; Hernández-Alcoceba, Rubén; Martín-Sánchez, Esperanza.
Affiliation
  • Mendaza S; Molecular Pathology of Cancer Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.
  • Fernández-Irigoyen J; Proteored-ISCIII, Proteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.
  • Santamaría E; Proteored-ISCIII, Proteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.
  • Arozarena I; Cancer Cell Signalling Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.
  • Guerrero-Setas D; Molecular Pathology of Cancer Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.
  • Zudaire T; Department of Pathology, Complejo Hospitalario de Navarra (CHN), Irunlarrea 3, 31008 Pamplona, Spain.
  • Guarch R; Department of Pathology, Complejo Hospitalario de Navarra (CHN), Irunlarrea 3, 31008 Pamplona, Spain.
  • Vidal A; Department of Pathology, Complejo Hospitalario de Navarra (CHN), Irunlarrea 3, 31008 Pamplona, Spain.
  • Salas JS; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, Carrer de la Feixa Llarga, 08907 L'Hospitalet de Llobregat, Spain.
  • Matias-Guiu X; CIBERONC, Centro de Investigación Biomédica en Red-Cáncer, 28029 Madrid, Spain.
  • Ausín K; Department of Pathology, Complejo Asistencial Universitario, Altos de Nava, 24071 León, Spain.
  • Gil C; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, Carrer de la Feixa Llarga, 08907 L'Hospitalet de Llobregat, Spain.
  • Hernández-Alcoceba R; CIBERONC, Centro de Investigación Biomédica en Red-Cáncer, 28029 Madrid, Spain.
  • Martín-Sánchez E; Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova, University of Lleida, Alcalde Rovira Roure 80, 25198 Lleida, Spain.
Cancers (Basel) ; 13(7)2021 Apr 06.
Article in En | MEDLINE | ID: mdl-33917510
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: Spain